0.64
price up icon0.76%   0.0048
after-market 시간 외 거래: .64
loading
전일 마감가:
$0.6352
열려 있는:
$0.6399
하루 거래량:
18,096
Relative Volume:
0.18
시가총액:
$17.85M
수익:
$8.59M
순이익/손실:
$-17.07M
주가수익비율:
-1.0492
EPS:
-0.61
순현금흐름:
$-21.90M
1주 성능:
-0.70%
1개월 성능:
+20.46%
6개월 성능:
-14.67%
1년 성능:
-51.15%
1일 변동 폭
Value
$0.6399
$0.6651
1주일 범위
Value
$0.60
$0.6669
52주 변동 폭
Value
$0.4801
$1.74

Durect Corp Stock (DRRX) Company Profile

Name
명칭
Durect Corp
Name
전화
(408) 777-1417
Name
주소
10240 BUBB ROAD, CUPERTINO, CA
Name
직원
14
Name
트위터
@DURECTCorp
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
DRRX's Discussions on Twitter

DRRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
DRRX
Durect Corp
0.64 17.85M 8.59M -17.07M -21.90M -0.61
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
14.60 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.19 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.35 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.37 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.64 20.17B 16.54B -1.64B 749.00M -1.45

Durect Corp Stock (DRRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-10-30 개시 Chardan Capital Markets Buy
2020-10-12 개시 ROTH Capital Buy
2020-07-31 개시 Oppenheimer Outperform
2020-01-31 개시 B. Riley FBR Buy
2019-11-18 재개 Cantor Fitzgerald Overweight
2019-09-06 개시 Cantor Fitzgerald Overweight
2018-03-06 업그레이드 H.C. Wainwright Neutral → Buy
2017-10-20 다운그레이드 H.C. Wainwright Buy → Neutral
2017-10-20 재확인 Laidlaw Buy
2017-10-20 다운그레이드 Stifel Buy → Hold
2017-07-12 업그레이드 Stifel Hold → Buy
2017-02-28 재개 H.C. Wainwright Buy
2016-04-25 개시 Rodman & Renshaw Buy
2015-05-01 재확인 Cantor Fitzgerald Buy
2015-05-01 재확인 Stifel Buy
2013-03-25 개시 Stifel Buy
2012-11-01 다운그레이드 C.K. Cooper Buy → Hold
2012-08-17 개시 C.K. Cooper Buy
2009-06-23 개시 Caris & Company Buy
2009-03-26 개시 Wedbush Morgan Hold
모두보기

Durect Corp 주식(DRRX)의 최신 뉴스

pulisher
Jun 10, 2025

Allay’s $57.5M extends postsurgical pain relief with ATX-101 - BioWorld MedTech

Jun 10, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Purchases 28,486 Shares of DURECT Co. (NASDAQ:DRRX) - Defense World

Jun 10, 2025
pulisher
May 23, 2025

Durect Corp stock hits 52-week low at $0.52 amid market challenges - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Durect Corp stock hits 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 22, 2025

Durect says ‍on July 24, Impax Laboratories terminated asset transfer and license agreement dated Jan. 3, 2014 - Reuters

May 22, 2025
pulisher
May 22, 2025

DURECT (NASDAQ:DRRX) Now Covered by Analysts at StockNews.com - Defense World

May 22, 2025
pulisher
May 15, 2025

Durect: Q1 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 14, 2025

DURECT (DRRX) Q1 Revenue Surpasses Estimates, Focuses on Phase 3 Trial Funding | DRRX Stock News - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Durect Corp Q1 2025 Earnings: EPS at -$0.13 Misses Estimate, Rev - GuruFocus

May 13, 2025
pulisher
May 13, 2025

DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 13, 2025
pulisher
May 10, 2025

DURECT (DRRX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
Apr 23, 2025

Durect Corp stock hits 52-week low at $0.69 amid market challenges By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Durect Corp stock hits 52-week low at $0.69 amid market challenges - Investing.com

Apr 23, 2025
pulisher
Apr 22, 2025

Form 8-KCurrent report - ADVFN

Apr 22, 2025
pulisher
Apr 21, 2025

DURECT Co. (NASDAQ:DRRX) Sees Large Decline in Short Interest - Defense World

Apr 21, 2025
pulisher
Apr 20, 2025

DURECT (NASDAQ:DRRX) Now Covered by StockNews.com - Defense World

Apr 20, 2025
pulisher
Apr 12, 2025

StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX) - Defense World

Apr 12, 2025
pulisher
Apr 09, 2025

Durect Corp stock hits 52-week low at $0.7 amid market challenges - Investing.com Canada

Apr 09, 2025
pulisher
Apr 04, 2025

DURECT (NASDAQ:DRRX) Coverage Initiated at StockNews.com - Defense World

Apr 04, 2025
pulisher
Mar 31, 2025

DURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call Transcript - MSN

Mar 31, 2025
pulisher
Mar 28, 2025

Here's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn Situation - Yahoo Finance

Mar 28, 2025
pulisher
Mar 27, 2025

DURECT Corporation’s Earnings Call Highlights Cost Cuts and Breakthrough Potential - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Durect Corp Q4 2024 Earnings: EPS of $0.25 Surpasses Estimates, Revenue Falls Short at $0.5 Million - GuruFocus

Mar 27, 2025
pulisher
Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic Focus Amid Financial Challenges - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic F - GuruFocus.com

Mar 27, 2025
pulisher
Mar 26, 2025

Durect: Q4 Earnings Snapshot - MySA

Mar 26, 2025
pulisher
Mar 26, 2025

Durect reports Q4 cont ops EPS (6c), consensus (2c) - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings call transcript: Durect’s Q4 2024 revenue drops as focus shifts to key drug - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

DURECT Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

DURECT Transforms Business: $17.5M Asset Sale, NEJM Evidence Validates Key Drug Program - Stock Titan

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings Scheduled For March 26, 2025 - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PR Newswire

Mar 26, 2025
pulisher
Mar 25, 2025

What To Expect From Durect Corp (DRRX) Q4 2024 Earnings - GuruFocus

Mar 25, 2025
pulisher
Mar 20, 2025

ARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance

Mar 20, 2025
pulisher
Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - Quantisnow

Mar 19, 2025

Durect Corp (DRRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$14.43
price up icon 1.05%
$9.18
price up icon 2.80%
$128.00
price up icon 1.84%
$290.91
price up icon 1.24%
drug_manufacturers_specialty_generic RDY
$14.94
price down icon 0.60%
$16.64
price down icon 0.72%
자본화:     |  볼륨(24시간):